ArticlePloS one2015

Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress.

Bo Zhai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.